Annual report [Section 13 and 15(d), not S-K Item 405]

EQUITY - Schedule of Stock Options Outstanding (Details)

v3.25.0.1
EQUITY - Schedule of Stock Options Outstanding (Details) - USD ($)
$ / shares in Units, $ in Thousands
 1 Months Ended 12 Months Ended
Sep. 13, 2024
Dec. 17, 2023
Sep. 30, 2024
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Stock Options            
Balance at beginning of period (in shares)       27,653,184 30,752,259  
Granted (in shares)     1,062,732 12,954,490 11,507,429  
Exercised (in shares)       (64,999)    
Cancelled/forfeited/expired (in shares)       (13,773,256) (14,606,504)  
Balance at end of period (in shares)       26,769,419 27,653,184 30,752,259
Exercisable (in shares)       11,209,397    
Weighted Average Exercise Price per Stock Options            
Balance at beginning of period (in dollars per share)       $ 1.40 $ 2.58  
Granted (in dollars per share) $ 0.54 $ 0.55   0.57 0.54  
Cancelled/forfeited/expired (in dollars per share)       1.81 3.20  
Exercised (in dollars per share)       0.60    
Balance at end of period (in dollars per share)       0.79 $ 1.40 $ 2.58
Exercisable (in dollars per share)       $ 0.99    
Aggregate Intrinsic Value            
Options Outstanding, Aggregate Intrinsic Value       $ 0 $ 0 $ 0
Exercisable       $ 0    
Weighted Average Remaining Contractual Life (in Years)            
Weighted Average Remaining Contractual Life       8 years 6 months 8 years 2 months 12 days 8 years 6 months
Exercisable       8 years